Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Tung Joseph — Shuttle Pharmaceuticals Holdings, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Tung Joseph

Tung Joseph

Director at Shuttle Pharmaceuticals Holdings, Inc. · on record since Mar 21, 2025
Director at Vemics, Inc. · on record since May 9, 2025

Insider trading activity of Tung Joseph

Transactions on record: 1; since Aug 12, 2025

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Aug 12, 2025

Figures computed from official regulatory filings — methodology.

Companies where Tung Joseph has traded

Shuttle Pharmaceuticals Holdings, Inc.1 tx · Aug 12, 2025

Track record of Tung Joseph

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Tung Joseph

Co-insiders of Tung Joseph

Chambers Adam VShuttle Pharmaceuticals Holdings, Inc. +1
Liriano AngelShuttle Pharmaceuticals Holdings, Inc. +1
1347 Property Insurance Holdings, Inc.Vemics, Inc.
Adkins WilliamShuttle Pharmaceuticals Holdings, Inc.
Brown MiltonShuttle Pharmaceuticals Holdings, Inc.
Chakravarthi MuralidarVemics, Inc.
Coddington F Chandler JrVemics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Cooper ChrisShuttle Pharmaceuticals Holdings, Inc.

DeSanti Robert AVemics, Inc.

Dorsett Thomas ChristopherVemics, Inc.

Douglas Donald BVemics, Inc.

Dritschilo AnatolyShuttle Pharmaceuticals Holdings, Inc.

Dritschilo PeterShuttle Pharmaceuticals Holdings, Inc.

Fidanza David A.Vemics, Inc.

FORTENBAUGH SAMUEL B IIIVemics, Inc.

Gitto JosephVemics, Inc.

Goetsch Harold LeeVemics, Inc.

Groh Brian RayVemics, Inc.

Howell Brian AnthonyVemics, Inc.

HRT FINANCIAL LPShuttle Pharmaceuticals Holdings, Inc.

Hyland Yvonne EVemics, Inc.

Jackson Paul DVemics, Inc.

Jacobs BetteShuttle Pharmaceuticals Holdings, Inc.

Jung MiraShuttle Pharmaceuticals Holdings, Inc.

Kalish Wayne EdwardVemics, Inc.

Liang YuyingShuttle Pharmaceuticals Holdings, Inc.

Lorber Timothy J.Shuttle Pharmaceuticals Holdings, Inc.

Malmanger Scott A.Vemics, Inc.

McDermott Kevin PatrickVemics, Inc.

McDermott Robert PVemics, Inc.

Nabyt OlehShuttle Pharmaceuticals Holdings, Inc.

Owens Thomas JosephVemics, Inc.

Pasqual JohnVemics, Inc.

Pathigoda Arachchige Sachin ErangaShuttle Pharmaceuticals Holdings, Inc.

PERISCOPE CAPITAL INC.Vemics, Inc.

Periscope SPAC Warrant Opportunity Fund LPVemics, Inc.

Piedra DavidVemics, Inc.

Richards Steven MShuttle Pharmaceuticals Holdings, Inc.

Rich TyvinShuttle Pharmaceuticals Holdings, Inc.

Schafer JoshuaShuttle Pharmaceuticals Holdings, Inc.

Schneller JohnVemics, Inc.

Schonfeld Strategic Advisors LLCVemics, Inc.

Scorsis GeorgeShuttle Pharmaceuticals Holdings, Inc.

Senanayake ChrisShuttle Pharmaceuticals Holdings, Inc.

Shah ArchitVemics, Inc.

Shemen Lawrence JVemics, Inc.

Smith JDVemics, Inc.

Smith Jerry DonVemics, Inc.

SPROAT DONALDVemics, Inc.

Stellinga Jefff WayneVemics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Shuttle Pharmaceuticals Holdings, Inc.	Aug 12, 2025	AwardD	29,240	0.00 USD	$0	SEC